LAWRENCE, Mass., Dec. 19, 2014 /PRNewswire/ -- Jeff Burbank, CEO and Founder of NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of
innovative dialysis products, spoke on Monday, December 15, 2014 among a panel of
Boston-based healthcare executives
at the EY Life Sciences Summit in Boston. While highlighting NxStage's mission
to pioneer the home hemodialysis market with its innovative System
One™, the first and only portable home hemodialysis system cleared
by the U.S. Food and Drug Administration (FDA), Burbank shared his
perspective on the increasing significance of innovations that can
improve the delivery of care.
Echoing a common theme in today's healthcare environment,
Burbank agreed that today's breakthrough innovations require a
clear economic value proposition that extends beyond clinical
benefits. He added that today, NxStage is advancing this
concept by providing customers with valuable integrated offerings
aimed at improving care delivery. Burbank commented, "At
NxStage, we are fortunate that the technology choices we made very
early on have proven to be the right ones to expand our reach into
other offerings that increase our value to customers. Our
patients and customers have played an equally important role in
helping us bring these innovations to market. We've learned a
tremendous amount from interacting directly with thousands of
patients over the past fourteen years. This experience is
invaluable. Without their continued support and feedback, we
could not bring breakthrough technology and solutions to the
market."
Burbank stated, "We've worked hard to ensure that our entire
business model is focused on improving the delivery of care- making
our therapy easier to administer and manage for both customers and
patients - whether through clinical work, product
development, customer support, integrated offerings and services,
training and education, or our market development initiatives.
In turn, this innovative model is driving market adoption and
unlocking tremendous growth opportunities in untapped areas for
NxStage."
About NxStage Medical, Inc.
NxStage is a medical device company, headquartered
in Lawrence, Massachusetts, USA, that develops, manufactures and markets
innovative products for the treatment of ESRD and acute kidney
failure. For more information on NxStage and its products, please
visit the Company's website at www.nxstage.com.
Forward-Looking Statements
This release
contains "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. All statements
contained in this release that are not clearly historical in nature
are forward-looking, and the words "anticipate," "believe,"
"expect," "estimate," "plan," and similar expressions are generally
intended to identify forward-looking statements. Actual results may
differ materially from those indicated by these forward-looking
statements as a result of various important factors including those
that are discussed in NxStage's filings with the Securities
and Exchange Commission, including the Quarterly Report on Form
10-Q for the quarter ended September 30, 2014. NxStage is
under no obligation to (and expressly disclaims any such obligation
to) update or alter its forward-looking statements, whether as a
result of new information, future events or otherwise.
Media contact:
Kristen K. Sheppard, Esq.
Vice President, Investor Relations and Corporate Counsel
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-founder-and-ceo-discusses-innovation-in-healthcare-at-ey-boston-life-sciences-summit-300012275.html
SOURCE NxStage Medical Inc.